Liver alterations are not improved by inulin supplementation in alcohol use disorder patients during alcohol withdrawal: A pilot randomized, double-blind, placebo-controlled study

安慰剂 内科学 胃肠病学 医学 益生元 菊粉 拟杆菌 肠道菌群 不利影响 随机对照试验 双歧杆菌 免疫学 生物 乳酸菌 病理 食品科学 替代医学 细菌 发酵 遗传学
作者
Camille Amadieu,Luca Maccioni,Sophie Leclercq,Audrey M. Neyrinck,Nathalie M. Delzenne,Philippe de Timary,Peter Stärkel
出处
期刊:EBioMedicine [Elsevier BV]
卷期号:80: 104033-104033 被引量:19
标识
DOI:10.1016/j.ebiom.2022.104033
摘要

BackgroundEmerging evidence highlights that targeting the gut microbiota could be an interesting approach to improve alcohol liver disease due to its important plasticity. This study aimed to evaluate the effects of inulin supplementation on liver parameters in alcohol use disorder (AUD) patients (whole sample) and in a subpopulation with early alcohol-associated liver disease (eALD).MethodsFifty AUD patients, hospitalized for a 3-week detoxification program, were enrolled in a randomized, double-blind, placebo-controlled study and assigned to prebiotic (inulin) versus placebo for 17 days. Liver damage, microbial translocation, inflammatory markers and 16S rDNA sequencing were measured at the beginning (T1) and at the end of the study (T2).FindingsCompared to placebo, AST (β = 8.55, 95% CI [2.33:14.77]), ALT (β = 6.01, 95% CI [2.02:10.00]) and IL-18 (β = 113.86, 95% CI [23.02:204.71]) were statistically significantly higher in the inulin group in the whole sample at T2. In the eALD subgroup, inulin supplementation leads to specific changes in the gut microbiota, including an increase in Bifidobacterium and a decrease of Bacteroides. Despite those changes, AST (β = 14.63, 95% CI [0.91:28.35]) and ALT (β = 10.40, 95% CI [1.93:18.88]) at T2 were higher in the inulin group compared to placebo. Treatment was well tolerated without important adverse events or side effects.InterpretationThis pilot study shows that 17 days of inulin supplementation versus placebo, even though it induces specific changes in the gut microbiota, did not alleviate liver damage in AUD patients. Further studies with a larger sample size and duration of supplementation with adequate monitoring of liver parameters are needed to confirm these results. Gut2Brain study: https://clinicaltrials.gov/ct2/show/NCT03803709FundingFédération Wallonie-Bruxelles, FRS-FNRS, Fondation Saint-Luc.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Menglong发布了新的文献求助10
刚刚
Parrot_PAI发布了新的文献求助10
1秒前
1秒前
1秒前
大个的应助被脆皮黑巧采纳,获得10
2秒前
研友_Lpaepn完成签到,获得积分10
2秒前
youziPrincess完成签到,获得积分10
2秒前
QDU关闭了QDU的文献求助
3秒前
3秒前
austinluo的应助被爱睡采纳,获得10
3秒前
狂野谷冬发布了新的文献求助10
4秒前
丘比特的应助被ZFYang采纳,获得10
4秒前
dsw发布了新的文献求助10
4秒前
笨笨如之完成签到 ,获得积分10
4秒前
5秒前
5秒前
5秒前
TT发布了新的文献求助10
6秒前
科研通AI6.2的应助被Jenny采纳,获得10
6秒前
木笔完成签到,获得积分10
8秒前
小晞完成签到 ,获得积分10
8秒前
mro发布了新的文献求助10
8秒前
领导范儿的应助被璇子采纳,获得10
8秒前
李健的应助被受不了12345采纳,获得10
9秒前
9秒前
爆米花的应助被hxm采纳,获得10
11秒前
Parrot_PAI完成签到,获得积分10
11秒前
MiyaGuo发布了新的文献求助10
12秒前
满意的山水完成签到,获得积分10
12秒前
思源的应助被快乐的菠萝采纳,获得10
12秒前
12秒前
13秒前
14秒前
14秒前
付创发布了新的文献求助10
14秒前
SS1988发布了新的文献求助10
15秒前
15秒前
16秒前
安静的缘分完成签到,获得积分10
17秒前
1123完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea De Guyane 2000
从自在到自觉:中华民族观念形成研究:全二册 800
Guidelines for fracture-safe and fatigue-reliable design of steel structures 600
Problems and Solutions for Integer and Combinatorial Optimization: Building Skills in Discrete Optimization 600
Organizational Behavior 510
桑白皮エキスの実験的, 臨床的育毛効果について 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 7999010
求助须知:如何正确求助?哪些是违规求助? 9452696
关于积分的说明 21140446
捐赠科研通 7572098
什么是DOI,文献DOI怎么找? 3380743
关于科研通互助平台的介绍 2513648
邀请新用户注册赠送积分活动 2414638